Phase II cancer vaccination trial with multiple peptides derived from novel oncoantigens against advanced esophageal cancer.
K. Kono
No relevant relationships to disclose
H. Iinuma
No relevant relationships to disclose
Y. Akutsu
No relevant relationships to disclose
H. Tanaka
No relevant relationships to disclose
N. Hayashi
No relevant relationships to disclose
Y. Uchikado
No relevant relationships to disclose
T. Noguchi
No relevant relationships to disclose
H. Fujii
No relevant relationships to disclose
R. Fukushima
No relevant relationships to disclose
H. Matsubara
No relevant relationships to disclose
K. Hirakawa
No relevant relationships to disclose
H. Baba
No relevant relationships to disclose
S. Natsugoe
No relevant relationships to disclose
S. Kitano
No relevant relationships to disclose
K. Yoshida
Employment or Leadership Position - OncoTherapy Science
T. Tsunoda
Employment or Leadership Position - OncoTherapy Science
Y. Nakamura
Stock Ownership - OncoTherapy Science